Advanced Filters
noise
Found 64,778 clinical trials
W Wiktor Kuliczkowski, MD PD

Lower Silesia Cardiogenic Shock Initiative

LSCSI is a Hub&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified …

18 - 60 years of age All Phase N/A
L Lynne Wolfe, M.S.

Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation

Background Proteins, fats, and other molecules are the body s building blocks. Many of these molecules must have sugars, or chains of sugars, attached to work properly. People with congenital disorders of glycosylation (CDGs) cannot attach these sugars or sugar chains properly. A child or adult with a CDG can …

1 - 80 years of age All Phase N/A
S Silvia Prades, PhD

CureDRPLA Global Patient Registry

The objective of the CureDRPLA Global Patient Registry is to establish a longitudinal database of patient-reported data on individuals affected with Dentatorubral-pallidoluysian atrophy (DRPLA) from anywhere in the world. The CureDRPLA Global Patient Registry will address patient needs by: Expanding patient engagement by documenting quality of life outcomes. Providing anonymized …

- 100 years of age All Phase N/A
K Khalid Maudood Siddiqui, FCPS

Oropharyngeal Airway and Airway Complications

Laryngeal Mask Airway has been used in paediatric anaesthesia since the 1990's. Clinical practice in paedeatric anaesthesia for Laryngeal Mask Airway removal varies and there is no standard of care. In children removing the Laryngeal Mask Airway under deep inhalational anaesthesia has some advantages compared to awake, but may be …

2 - 10 years of age All Phase N/A
J Jenny Haen

Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms

This is a prospective, non-randomized, single center, data collection study of patients treated with open surgical repair (OR) for complex aortic aneurysms (CAAs).

18 years of age All Phase N/A

Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation

The study aims at searching for a genotype-phenotype correlation in patients with a genetic pathology of the ocular surface, in order to identify genetic abnormalities associated with the most severe clinical situations.

years of age All Phase N/A
T Tiziana Bachetti

Neural Bases of Social Cognitive Processing in Healthy Individuals

The goal of this single center non-interventional fMRI and EEG study is to assess the neural bases of social cognitive processing in healthy individuals, and whether/how their responsiveness is modulated by ageing. The main questions it aims to answer are: are there specific brain regions where individual differences in social …

18 - 60 years of age All Phase N/A
A Adel Elgergawy, MD

Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study

uterine NK (uNK) cells are characterized by a high expression of CD56 (CD56brihgt), lack of CD16 expression, high secretion of cytokines and rather low cytotoxic activity. It has been shown that uNK cells increase in number during the late secretory phase and during early pregnancy. This study was designed to …

20 - 40 years of age Female Phase N/A
L Liyun Lu

Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke. The main questions it aims to answer are: the optimal target body temperature at 0.5 h, 2 h, and the …

18 years of age All Phase N/A

BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment

The presence of a BRAFV600E mutation is a marker of poor prognosis in patients with mCRC and associated with a median overall survival (mOS) of approximately 12 to 14 months compared to 20 to 25 months for patients with BRAF wild-type tumours. After 1st line therapy, treatment outcomes with standard …

18 years of age All Phase N/A

Simplify language using AI